Illumina Inc. (NASDAQ:ILMN) ranks among the top NASDAQ stocks with low P/E ratios. On September 23, Illumina Inc. (NASDAQ:ILMN) announced that it would collaborate with several global pharmaceutical companies to create companion diagnostics (CDx) for KRAS biomarkers on its TruSight Oncology Comprehensive genomic profiling test. The collaborations are intended to increase tumor-agnostic CDx claims for KRAS mutations, which are known to result in uncontrolled cell growth that can lead to cancer. By identif ...